Immune checkpoint inhibitors in gynecologic cancers with lessons learned from non-gynecologic cancers
2016
ABSTRACTIntroduction: The immune system plays a critical role in controlling cancer through a dynamic relationship with cancer cells. Immunotherapy can establish a sustained immune response against recurring cancer cells leading to long-term remissions for cancer patients. The use of immune checkpoint inhibitors, which work by targeting molecules that regulate immune responses, might be a promising avenue of immunotherapeutic research in gynecologic cancers.Areas covered: This review focuses on the use of immune checkpoint inhibitors targeting cytotoxic T lymphocyte antigen-4 (CTLA-4) and the programmed death receptors such as PD-1 and PD1-ligand in gynecologic cancers. Combinatorial approaches utilizing immunotherapeutic agents with conventional treatments as well as immune-related response criteria and the adverse effects arising due to checkpoint inhibitor immunotherapy have been also discussed in the review.Expert opinion: After years of very little success, a better understanding of the pivotal role ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
120
References
4
Citations
NaN
KQI